Trademark: 97636703
Word
SYNHLA
Status Date
Monday, May 6, 2024
Filing Date
Tuesday, October 18, 2022
Published for Opposition
Tuesday, August 8, 2023
Abandoned Date
Monday, May 6, 2024
5 Pharmaceutical preparations for cell therapy to treat human diseases and disorders; cell therapy products, namely, pharmaceutical preparations to treat cellular disorders, namely, human diseases and disorders
42 Scientific research and development; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; scientific research and development of technology in the field of cell therapy; scientific testing, inspection, research, and development of pharmaceutical preparations for cell therapy
Apr 4, 2023
Non-Final Action Written
Oct 21, 2022
New Application Entered
Nov 1, 2022
New Application Office Supplied Data Entered
Jan 11, 2023
Automatic Update Of Assignment Of Ownership
Mar 20, 2023
Assigned To Examiner
Apr 4, 2023
Non-Final Action E-Mailed
Apr 4, 2023
Notification Of Non-Final Action E-Mailed
Jun 29, 2023
Teas Response To Office Action Received
Jun 29, 2023
Correspondence Received In Law Office
Jun 30, 2023
Teas/Email Correspondence Entered
Jul 3, 2023
Approved For Pub - Principal Register
Jul 19, 2023
Notification Of Notice Of Publication E-Mailed
Aug 8, 2023
Published For Opposition
Aug 8, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 3, 2023
Noa E-Mailed - Sou Required From Applicant
May 6, 2024
Abandonment - No Use Statement Filed
May 6, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Trademark Alertz updated from USPTO on 2030-01-24
